PENDOPHARM offers a portfolio of orthobiologics that offer treatment options for musculoskeletal disorders. CINGAL®, MONOVISC® and ORTHOVISC® are hyaluronic acid (HA) supplements for the treatment of pain due to osteoarthritis of the knee, a condition increasingly impacting Canadians of all ages. SPORTVISTM is the first HA supplement indicated to relieve pain and restore function in damaged tendons and ligaments.
SportVis™ and STABHA™ are trademark of MDT Int’l s.a. Cingal®, Monovisc® and Orthovisc® are registered trademarks of Anika Therapeutics, Inc., used under licence by Pharmascience Inc.
Cingal® is a single-injection osteoarthritis knee pain relief treatment that combines the fast relief of a corticosteroid with the long-lasting relief of a viscosupplement.Read More
Monovisc® is single intra-articular injection of cross-linked sodium hyaluronate designed to treat the symptoms of osteoarthritis.Read More
Orthovisc® is an intra-articular injection indicated for the symptomatic treatment of osteoarthritis of the knee.Read More
SportVis™ is a peri-articular injection of STABHA™ (soft tissue adapted biocompatible hyaluronic acid) indicated to relieve pain and restore function in damaged tendons and ligaments.Read More